CLEARPATH:

Early Detection of Diabetic Risk

The CDC reports that 27.8% of people with diabetes are not diagnosed. People with diabetes are at higher risk of serious health complications INCLUDING blindness.

Diabetes, whether Type 1 or Type 2, can cause a myriad of complications in the eye including diabetic retinopathy, early onset cataracts, shifts in refractive error, or even blindness. Diabetic retinopathy is the breakdown of the walls of blood vessels within the retina leading to bleeding or accumulation of fluid. The two main factors associated with diabetic retinopathy are duration and control of diabetes. Even with strict control, all diabetes should have a yearly comprehensive eye exam with dilation to evaluate for possible complications.

Piedmont Eyecare is proud to be one of the few practices in the southeast to offer ClearPath technology to assess your risk factor for developing diabetes. The ClearPath device measures the amount of sugar within the lens of the eye. A higher value of sugar in the lens equates to a higher blood sugar level. ClearPath has been shown to detect your diabetic risk up to 7 years in advance of abnormal blood findings.

Now offered at Piedmont EyeCare

CLEARPATH technology, developed by Harvard University, provides a six second scan to indicate if you’re at risk for diabetes up to 7 years before symptoms display! Early detection and intervention that lead to lifestyle changes reduce the risk of diabetic retinopathy by 76%

ClearPath device picture

How CLEARPATH Works

This device scans the eye with a blue light, measuring the intensity of light emitted by the eye. When there’s too much sugar in a patient’s body, sugar molecules start binding to proteins in the lens of the eye. A higher measure corresponds to higher levels of glucose build-up in the eye.

Ask our staff about this important test and if it’s right for you!